NuGen Medical Devices Inc. (TSXV:NGMD)

Market Cap	15.89M
Revenue (ttm)	1.01M
Net Income (ttm)	-5.23M
Shares Out	227.04M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,000
Average Volume	195,617
Open	0.0650
Previous Close	0.0700
Day's Range	0.0650 - 0.0700
52-Week Range	0.0400 - 0.1550
Beta	2.56
RSI	48.28
Earnings Date	May 1, 2025

About NuGen Medical Devices

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Lin Liang
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NGMD

Financial Performance

In 2024, NuGen Medical Devices's revenue was 1.01 million, an increase of 204.73% compared to the previous year's 331,403. Losses were -5.23 million, -44.18% less than in 2023.